Sleep Apnea Central
20
1
1
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
5.0%
1 terminated out of 20 trials
92.3%
+5.8% vs benchmark
15%
3 trials in Phase 3/4
67%
8 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (20)
Assessing the Performance of Wesper Lab for Obstructive and Central Sleep Apnea
Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome
Apnea, Stroke and Incident Cardiovascular Events
Comparison of CPAP With SOMNOventCR in Patients With Underlying Heart Disease, Combined OSA and CSR
Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude
DreamKit Diagnostic Validation
DreamKit Respiratory Effort Signal Validation
Early Sleep Apnea Treatment in Stroke
Sparkle Respiratory Effort Validation
Benefit of One Month Zopiclone Intake on Adaptative Servoventilation Compliance
Evaluation of ApneaLink Plus Scoring Capabilities
Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea
Variable Dead Space Rebreathing Device to Treat Sleep Apnea
Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders
Evaluation of Software Enhancements to the Respironics BiPAP Auto Servo Ventilation (AutoSV) Device
Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography
Respicardia, Inc. Pivotal Trial of the remedē System
Application of Forced Breath Technique While CPAP Therapy for Apnea Classification
Bipap Automatic Servo Ventilation (autoSV) Advanced in Central Apnea Patients
Dynamic Carbon Dioxide (CO2) Administration for Sleep Apnoea